Effect of dexmedetomidine on brain edema and neurological outcomes in surgical brain injury in rats

Anesthesia and Analgesia

Volumn 115, Issue 1, 2012, Pages 154-159

  Benggon, Michael ^a   Chen, Han ^b   Applegate, Richard ^a   Martin, Robert ^a   Zhang, John H ^b  

^a Department of Anesthesiology ^*  (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN WATER; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HEART RATE; HYPOTHESIS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; SURGICAL INJURY;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BRAIN; BRAIN EDEMA; BRAIN INJURIES; DEXMEDETOMIDINE; DISEASE MODELS, ANIMAL; HEART RATE; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; NEUROLOGIC EXAMINATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84862976648     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31824e2b86     Document Type: Article

References (30)

1. Am Association of Neurological Surgeons. National Neurosurgical Procedural Statistics 2006 Survey. AANS 2008; Rolling Meadows, IL. (https://www.myaans.org/desktopmodules/ directory/ProcedStat2006.pdf) [Accessed 23 May 2011]
2. Jadhav V, Matchett G, Hsu FPK, Zhang JH. Inhibition of Src tyrosine kinase and effect on outcomes in a new in vivo model of surgically induced brain injury. J Neurosurg 2007;106: 680-86
3. Matchett G, Hahn J, Obenaus A, Zhang JH. Surgically induced brain injury in rats: the effect of erythropoietin. J Neurosci Meth 2006;158:234-41
4. Yamaguchi M, Jadhav V, Obenaus A, Colohan A, Zhang JH. Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury. Neurosurgery 2007;61:1067-76
5. Hyong A, Jadhav V, Lee S, Tong W, Rowe J, Zhang JH, Tang J. Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents. Brain Res 2008;1215: 218-24
6. Lo W, Bravo T, Jadhav V, Titova E, Zhang JH, Tang J. NADPH oxidase inhibition improves neurological outcomes in surgically-induced brain injury. Neurosci Lett 2007;414:228-32
7. Raichle ME, Hartman BK, Eichling JO, Sharpe LG. Central noradrenergic regulation of cerebral blood flow and vascular permeability. P Natl Acad Sci USA 1975;72:3726-30
8. Kalaria RN, Stockmeier CA, Harik SI. Brain microvessels are innervated by locus ceruleus noradrenergic neurons. Neurosci Lett 1989;97:203-8
9. Harik S. Blood-brain barrier sodium/potassium pump: modulation by central noradrenergic innervation. P Natl Acad Sci USA. 1986;83:4067-70
10. Borges N, Sarmento A, Azevedo I. Dynamics of experimental vasogenic brain oedema in the rat: changes induced by adrenergic drugs. J Auton Pharmacol 1999;19:209-17
11. Sarmento A, Borges N, Lima D. Influence of electrical stimulation of locus ceruleus on the rat blood-brain barrier permeability to sodium fluorescein. Acta Neurochir 1994;127:215-9
12. Moss RF, Parmar NK, Tighe D, Davies DC. Adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis. Crit Care Med 2004;32:1916-21
13. Cassuto J, Tarnow P, Yregard L, Lindblom L, Rantfors J. Adrenoceptor subtypes in the control of burn-induced plasma extravasation. Burns 2005;31:123-9
14. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha-2 adrenergic antagonist atipamezole. Anesthesiology 1991;75:328-32
15. Engelhard K, Werner C, Eberspacher E, Bachl M, Blobner M, Hildt E, Hutzler P, Kochs E. The effect of the 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003;96:524-31
16. Kuhmonen J, Pokorny J, Miettinen R, Haapalinna A, Jolkkonen J, Riekkinen P, Sivenius J. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997;87:371-7
17. Kuhmonen J, Haapalinna A, Sivenius J. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm 2001;108:261-71
18. Goyagi T, Nishikawa T, Tobe Y, Masaki Y. The combined neuroprotective effects of lidocaine and dexmedetomidine after transient forebrain ischemia in rats. Acta Anaesthesiol Scand 2009;53:1176-83
19. Sato K, Kimura T, Nishikawa T, Tobe Y, Masaki Y. Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand 2010;54:377-82
20. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995;26: 627-34
21. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000;39:777-87
22. Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the european cooperative acute stroke study (ECASS) I. Stroke 1999;30:2631-6
23. Jadhav V, Ostrowski RP, Tong W, Matus B, Jesunathadas R, Zhang JH. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Stroke 2009;40:3139-42
24. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004;18:1291-3
25. Li PA, Shamloo M, Smith ML, Katsura K, Siesjo BK. The influence of plasma glucose concentrations on ischemic brain damage is a threshold function. Neurosci Lett 1994;177:63-5
26. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993;78:813-20
27. Uyar AS. Dexmedetomidine attenuates the hemodynamic and neuroendocrinal responses to skull-pin head-holder application during craniotomy. J Neurosurg Anesthesiol 2008;20: 174-9
28. Bekker AY, Kaufman B, Samir H, Doyle W. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001;92:1251-3
29. Rozet I, Muangman S, Vavilala MS, Lee LA, Souter MJ, Domino KJ, Slimp JC, Goodkin R, Lam AM. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in parkinson's disease. Anesth Analg 2006;103:1224-8
30. Stapelfeldt C, Lobo EP, Brown R, Talke PO. Intraoperative clonidine administration to neurosurgical patients. Anesth Analg 2005;100:226-32